account_circleRecruiting
Pregnancy, Unplanned
Bayer Identifier:
16470
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
European Active Surveillance Study of LCS-12
Trial purpose
This study is designed to investigate whether LCS12 is associated with an increased risk of unintended pregnancy compared to Mirena and to copper IUDs. The objective is to assess among new users the risks of certain events (e.g. contraceptive failure rate, ectopic pregnancy, uterine perforation, and PID) associated with the use of LCS12 compared with the established hormonal IUD Mirena, and compared with established copper IUDs during standard clinical practice. In addition, drug utilization patterns will be described.
Key Participants Requirements
Sex
FemaleAge
NaN - 39 YearsTrial summary
Enrollment Goal
83000Trial Dates
June 2014 - December 2026Phase
Phase 4Could I Receive a placebo
N/AProducts
Skyla (Levonorgestrel, BAY86-5028)Accepts Healthy Volunteer
YesWhere to participate
Status | Institution | Location |
---|---|---|
Recruiting | Many locations, Germany | |
Recruiting | Many locations, United Kingdom | |
Recruiting | Many locations, Poland | |
Recruiting | Many locations, Austria | |
Recruiting | Many locations, France | |
Recruiting | Many locations, Sweden | |
Recruiting | Many locations, Czech Republic | |
Recruiting | Many locations, Finland | |
Recruiting | Many locations, Italy | |
Recruiting | Many locations, Spain |
Primary Outcome
- Contraceptive failuredate_rangeTime Frame:within 3 years
Secondary Outcome
- Pelvic inflammatory disease (PID)date_rangeTime Frame:within 3 - 5 years
- Ectopic pregnancydate_rangeTime Frame:within 3 - 5 years
- Uterine perforationsdate_rangeTime Frame:within 3 - 5 years
- Contraceptive failure (Kyleena vs. Mirena and copper IUDs)date_rangeTime Frame:within 5 years
Trial design
Trial Type
ObservationalIntervention Type
N/ATrial Purpose
OtherAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A